Thank you to the #VJDementia and Dr. James Galvin for taking time out of a busy #ADPD2026 to discuss results from our Phase 2 study of #zervimesine in #dementia with Lewy bodies (DLB): lnkd.in/e_9Cw3N2.

#DementiaWithLewyBodies #DLBPsychosis #DementiaSupport #LewyStrong #Hallucinations #Delusions

$CGTX reported 4Q and YE2025 financial results last week: ir.cogrx.com/events/. During the webcast, CEO Lisa Ricciardi commented on the high level of interest in #zervimesine among participants in the DLB expanded access program.

#ClinicalResearch #DementiaWithLewyBodies #DLBPsychosis #LewyStrong

Thank you #ADPD2026 for another excellent meeting. The $CGTX team returned with a renewed excitement about the state of the science and clinical development in neurodegenerative diseases.

#Neurology #ClinicalResearch #BiotechInnovation #DLBpsychosis